Fortis Healthcare informs about disclosure

21 Dec 2024 Evaluate
Pursuant to the provisions of Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015 (‘SEBI Listing Regulations’) and in continuation of its intimation dated August 9, 2024, Fortis Healthcare has informed that the Company on December 20, 2024 at 07:18 pm (IST) has acquired 5,970,149 equity shares as held by International Finance Corporation (‘IFC’) (representing 7.61% equity stake) in Agilus Diagnostics (a material subsidiary of the Company) from IFC. Details as required under SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, is enclosed as Annexure A.

The above information is a part of company’s filings submitted to BSE.

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×